Literature DB >> 16539387

Are target-family-privileged substructures truly privileged?

Dora M Schnur1, Mark A Hermsmeier, Andrew J Tebben.   

Abstract

One of the early and effective approaches to G-coupled protein receptor target family library design was the analysis of a set of ligands for frequently occurring chemical moieties or substructures. Various methods ranging from frameworks analysis to pharmacophores have been employed to find these so-called target-family-privileged substructures. Although the use of these substructures is common practice in combinatorial library design and has produced leads, the methods used for finding them rarely verified their selectivity for the particular target family from which they were derived. The frequency of occurrence among ligands associated with a target receptor family is not a sufficient criterion for those substructures to receive the label of target-family-privileged substructure. This study explores the question of selectivity of ClassPharmer generated fragments for a series of target families: GPCRs, nuclear hormone receptors, serine proteases, protein kinases, and ligand-gated ion channels. In addition, a GPCR focused library and a random set of 10k compounds are examined in terms of their target-family-privileged-substructure composition. The results challenge the combinatorial chemistry concept of target-family-privileged substructures and suggest that many of these fragments may simply be drug-like or attractive for various receptors in accordance with the original definition of privileged substructures.

Mesh:

Substances:

Year:  2006        PMID: 16539387     DOI: 10.1021/jm0502900

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins.

Authors:  Hak Jun Kim; Stanley C Howell; Wade D Van Horn; Young Ho Jeon; Charles R Sanders
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-11-01       Impact factor: 9.795

Review 2.  Chemogenomic approaches to rational drug design.

Authors:  D Rognan
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

3.  The use of blue native PAGE in the evaluation of membrane protein aggregation states for crystallization.

Authors:  Jichun Ma; Di Xia
Journal:  J Appl Crystallogr       Date:  2008-11-11       Impact factor: 3.304

4.  In silico prediction of ROCK II inhibitors by different classification approaches.

Authors:  Chuipu Cai; Qihui Wu; Yunxia Luo; Huili Ma; Jiangang Shen; Yongbin Zhang; Lei Yang; Yunbo Chen; Zehuai Wen; Qi Wang
Journal:  Mol Divers       Date:  2017-08-02       Impact factor: 2.943

5.  Exploring target-selectivity patterns of molecular scaffolds.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  ACS Med Chem Lett       Date:  2010-02-01       Impact factor: 4.345

6.  A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.

Authors:  Eelke van der Horst; Julio E Peironcely; Adriaan P Ijzerman; Margot W Beukers; Jonathan R Lane; Herman W T van Vlijmen; Michael T M Emmerich; Yasushi Okuno; Andreas Bender
Journal:  BMC Bioinformatics       Date:  2010-06-10       Impact factor: 3.169

7.  Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; Benjamin Z Stanton; Jotaro Igarashi; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

8.  Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Front Pharmacol       Date:  2015-05-13       Impact factor: 5.810

9.  Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept.

Authors:  Michael Lisurek; Bernd Rupp; Jörg Wichard; Martin Neuenschwander; Jens Peter von Kries; Ronald Frank; Jörg Rademann; Ronald Kühne
Journal:  Mol Divers       Date:  2009-08-15       Impact factor: 2.943

10.  Construction of Quantitative Structure Activity Relationship (QSAR) Models to Predict Potency of Structurally Diversed Janus Kinase 2 Inhibitors.

Authors:  Saw Simeon; Nathjanan Jongkon
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.